Chromatin immunoprecipitation, promoter mutagenesis and target specific siRNAs were then utilized to identify ETS1 as the transcription factor regulating EGFR-MEK1/2-dependent CIP2A expression in human cancers. This evidence concerns the gene CIP2A and cancer.